News | EP Lab | August 27, 2019

Lenox Hill Hospital Opens New Heart Rhythm Center

New York facility includes new procedural lab with state-of-the-art electrophysiology procedures and technologies

Lenox Hill Hospital Opens New Heart Rhythm Center

August 27, 2019 – Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to the treatment of heartbeat abnormalities. The facility, which includes a brand new procedural laboratory, will offer patients a state-of-the-art program delivering cutting-edge electrophysiology procedures, including complex ablations, minimally-invasive pacemaker and defibrillator implantations, and structural interventions. The space also includes a newly renovated reception area and a comfortable, tranquil waiting room for patients’ families and friends.

The revitalization of the reception area was made possible thanks to a gift by longtime Northwell Health donor Susan Merinoff. The “Susan and Herman Merinoff Reception” space bears her name as well as that of her late husband. Merinoff and her family have been loyal supporters of the health system for several decades, previously helping endow such services as the Palliative Medicine Program at Lenox Hill and the Center for Patient-Oriented Research at The Feinstein Institute for Medical Research.

“We are extremely grateful for Mrs. Merinoff’s generosity in helping us reinvigorate and expand our electrophysiology services,” said Nicholas Skipitaris, M.D., director of electrophysiology at Lenox Hill. “We will continue to provide innovative care to our patients, and now we can also offer a beautiful, dedicated space for their families to gather while they support their loved ones.”

Cardiac arrhythmia is a fairly common medical condition in which the heart’s internal electrical system malfunctions causing problems in the rate or rhythm of the heartbeat. According to the American Heart Association, more than 4 million Americans suffer from recurrent arrhythmias. While most arrhythmias are harmless, some may be serious enough to cause organ damage, heart attack, stroke or even death if left untreated.

Lenox Hill Heart & Lung, the cardiac and pulmonary service line of the hospital, is equipped with the latest technology to manage and treat the various types of arrhythmias, providing a range of minimally-invasive treatments. In addition, Lenox Hill was one of the first medical centers in the nation to offer Medtronic’s CardioInsight sensor vest mapping-system to quickly, accurately and non-invasively identify the exact site of an electrical malfunction within the heart.

“The Heart Rhythm Center continues the growth of Lenox Hill Hospital’s cardiology services with a patient and family centered facility dedicated to the treatment heartbeat abnormalities,” said Varinder Singh, M.D., chair of cardiovascular medicine at Lenox Hill Hospital and chair of cardiovascular services for the northwest region of Northwell Health. “As one of the nation’s leaders in cardiac care, our team of nationally recognized electrophysiology specialists uses the latest techniques and devices to help monitor, control and maintain a healthy heartbeat.”

For more information: www.northwell.edu

Related Content

HRS study finds Frequent Coffee Consumption Lowers Chance of Arrhythmias. #HRS #HRS20 Heartrhythm20
News | EP Lab | May 28, 2020
May 28, 2020 – A recent study revealed that drinking a couple of cups of coffee per day does not lead to a greater ri
he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

News | EP Lab | May 20, 2020
May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of...
Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.
News | EP Lab | May 19, 2020
May 19, 2020 – Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), an
HRS presentations included BlueSync Evaluation study for Medtronic MyCareLink Heart mobile app and Micra TPS CED Study
News | EP Lab | May 14, 2020
May 14, 2020 – Medtronic announced results from late-breaking clinical trials evaluating the MyCareLink Heart mobile
Etripamil Nasal Spray Does Not Meet Primary Endpoint in Treating Supraventricular Tachycardia in the NODE-301 trial presented at Heart Rhythm 2020. #heartrhythm2020 #HRS2020
News | EP Lab | May 13, 2020
May 13, 2020 — The patient-administered nasal spray drug etripamil did not meet its primary endpoint in treating pati
Medtronic Cobalt and Crome ICD
News | EP Lab | May 12, 2020
May 12, 2020 — Medtronic has received FDA approval for its Cobalt and Crome implantable cardioverter-defibrillators (
The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time. FDA clears, approved, the HeartLight X3 Laser Ablation System to Treat Atrial Fibrillation.

The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time.

News | EP Lab | May 12, 2020
May 12, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the next-generation CardioFocus Inc.
EP lab photo from Philips Healthcare
News | EP Lab | April 30, 2020
May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to edu
The European Heart Rhythm Association (EHRA) electrophysiology (EP) annual meeting cancelled due to coronavirus. #COVID19 #coronavirus #2019nCoV
Feature | EP Lab | March 10, 2020 | Dave Fornell, Editor
March 10, 2020 — Novel coronavirus (...
The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical SuperMap, an addition to its AcQMap 3-D imaging and mapping system used to guide electrophysiology (EP) catheter ablation procedures. Adding the SuperMap mode to the AcQMap system enables users to visualize any atrial rhythm in less than three minutes. Rapidly mapping and re-mapping the whole heart chamber facilitates a new procedural workflow in EP ablation, making it practical to execute an iterative "map, ablate, re-map" approach.
News | EP Lab | March 05, 2020
March 5, 2020 — The U.S.